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A Genomewide Single-Nucleotide–Polymorphism Panel
for Mexican American Admixture Mapping
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Gabriel Silva, John W. Belmont, Robert L. Hanson, William C. Knowler, Peter K. Gregersen,
Dennis G. Ballinger, and Michael F. Seldin
For admixture mapping studies in Mexican Americans (MAM), we deﬁne a genomewide single-nucleotide–polymorphism
(SNP) panel that can distinguish between chromosomal segments of Amerindian (AMI) or European (EUR) ancestry.
These studies used genotypes for 1400,000 SNPs, deﬁned in EUR and both Pima and Mayan AMI, to deﬁne a set of
ancestry-informative markers (AIMs). The use of two AMI populations was necessary to remove a subset of SNPs that
distinguished genotypes of only one AMI subgroup from EUR genotypes. The AIMs set contained 8,144 SNPs separated
by a minimum of 50 kb with only three intermarker intervals 11 Mb and had EUR/AMI values 10.30 (meanF F pST ST
) and Mayan/Pima values !0.05 (mean ). Analysis of a subset of these SNP AIMs suggested that this0.48 F F ! 0.01ST ST
panel may also distinguish ancestry between EUR and other disparate AMI groups, including Quechuan from South
America. We show, using realistic simulation parameters that are based on our analyses of MAM genotyping results, that
this panel of SNP AIMs provides good power for detecting disease-associated chromosomal segments for genes with
modest ethnicity risk ratios. A reduced set of 5,287 SNP AIMs captured almost the same admixture mapping information,
but smaller SNP sets showed substantial drop-off in admixture mapping information and power. The results will enable
studies of type 2 diabetes, rheumatoid arthritis, and other diseases among which epidemiological studies suggest differ-
ences in the distribution of ancestry-associated susceptibility.
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Admixturemapping is a promisingmethod for identifying
chromosomal regions containing ancestry-linked traits
when the distribution of the susceptibility genes is differ-
ent among the founding populations.1–4 Recent admix-
ture mapping studies of African Americans (AFA) provide
strong evidence of susceptibility regions for multiple scle-
rosis and prostate cancer associated with ancestry.5,6 These
investigations have underscored the potential value of ap-
plying this approach to diverse admixed populations and
multiple common diseases. In particular, there is substan-
tial interest in applying this method toward studies of type
2 diabetesmellitus (MIM#125853) and its complications7,8
and autoimmune diseases, including rheumatoid arthritis
(MIM #180300), in Amerindian (AMI) admixed popula-
tions. Epidemiological studies indicate that AMI popula-
tions have unusually high prevalences of these diseases
compared with European populations (EUR).9–11 The very
large populations of Mexican Americans (MAM) and Mes-
tizo Mexicans with large variance in AMI and EUR12 con-
tributions suggests that admixture mappingmethodsmay
be particularly useful for genetic analysis of these common
complex diseases with high morbidity. The current study
emerged from the need to develop these markers for the
Family Investigation of Nephropathy and Diabetes (FIND),
as described elsewhere.8
In contrast with studies of African and EUR admixed
populations, the application of admixture mapping in
MAM populations has been limited by the relatively small
number of markers that have been identiﬁed that distin-
guish between AMI and EUR populations. Although sev-
eral hundred markers identiﬁed elsewhere have allowed
analysis of the population-genetics structures of AMI ad-
mixed populations,12–17 admixture mapping requires sev-
eral thousand ancestry-informative markers (AIMs) for ge-
nomewide deﬁnition of chromosomal segments. The num-
ber of AIMs necessary for admixture mapping is, in part,
a function of the number of generations since admixture
in the study population. Ascertainment of these admixture
characteristics for MAM and other AMI admixed popula-
tions has likewise been hampered by the relative paucity
of AIMs. Large numbers of AIMs are necessary to estimate
this parameter from ancestry deﬁnition of chromosomal
segments—that is, identiﬁcation of ancestry recombina-
tion events that have occurred along each chromosome.
www.ajhg.org The American Journal of Human Genetics Volume 80 June 2007 1015
The current study addresses the need for AIMs that are
useful for admixture mapping in MAM and examines the
parameters necessary for studying this population.
A potential problem in deﬁning AIMs and applying ad-
mixture mapping is the inability to study the actual pa-
rental populations that contributed to the current ad-
mixed populations. Although previous studies have sug-
gested that the differences in allele frequencies within dif-
ferent continental populations13,15,18–20 is relatively small
compared with differences between continental popula-
tions, this issue remains a concern. In the current study,
we have used Pima Indians, a northern Uto-Aztecan AMI
group, as our initial representative of the AMI contribu-
tion to MAM. Importantly, we have also examined a sec-
ond disparate AMI group, Mayan (a group that does not
speak a Uto-Aztecan language), in our assessment ofmarker
and population characteristics. Another problem is admix-
ture within the presumptive parental population, a factor
that deserves special consideration in indigenous AMI
populations in the Americas, where many AMI groupsmay
have a history of substantial EUR gene ﬂow. This issue was
addressed both by our careful selection of participants and
by screening those subjects with small numbers of EUR/
AMI/AFR AIMs, to identify and exclude clear population
outliers from these studies (see the “Methods” section).
Recently, we reported a set of AIMs that provide exten-
sive genomewide coverage for admixture mapping in AFA
and that took advantage of HapMap genotyping results,
including genotyping data from ∼3.5 million SNPs.19 This
strategy could not be used in the present study, because
large-scale analysis of SNP variations in AMI populations
had not yet been performed. In the present work, we used
two different strategies to screen and partially validate a
set of AIMs for MAM admixture mapping: (1) a screen of
the Illumina 100K gene-rich and 317K HapMap SNP–en-
riched SNP arrays and (2) a set of ∼20,000 SNPs selected
for informativeness between East Asian and EUR popu-
lations. The latter strategy was suggested by our previous
studies13 in which a 10-fold enrichment in the frequency
of EUR/AMI SNP AIMs was achieved by selecting SNPs
with East Asian/EUR , compared with randomF 1 0.30ST
SNPs. Together, these strategies identiﬁed large numbers
of SNP AIMs and provide a strong basis for admixture
mapping studies in MAM.
Methods
Population Samples
DNA samples or genotyping results from230EuropeanAmericans
(EURNY), 274 EURs (EURNIHLN), 60 CEPH EURs (CEU), 72 Pima
AMIs, 29 Mayan AMIs, 48 Quechuan AMIs, 24 Nahua AMIs, 24
MAM, and 90 East Asians (Japanese from Tokyo [JPT] and Han
Chinese from Beijing [CHB]) were included in various aspects of
this study. These populations were based on self-identiﬁed ethnic
afﬁliation. The EURNY were from New York City; Pima individ-
uals were from Arizona (samples provided by R.L.H. andW.C.K.);
Mayan and Quechuan individuals were from Guatemala and
Peru, respectively (samples provided by G.S. and J.B.); the Nahua
were from central Mexico (samples donated by Dr. David Smith
of the University of California–Davis [UC-Davis]), and the MAM
were from California. (The admixture characteristics of this Ma-
yan group is very different from theMayan subjects in theHuman
Diversity Panel who have been reported to have European ad-
mixture.16) The CEU, JPT, and CHB were the HapMap panel ge-
notypes,21 and the EURNIHLN genotypes were available from the
National Institutes of Health (NIH) Laboratory of Neurogenetics
at the Queue at Coriell Web site. All DNA and blood samples were
obtained in accordance with protocols and informed-consent
procedures approved by institutional review boards and were la-
beled with an anonymous code number or, in the case of the
MAM, in accordance with approved procedures. The studied sub-
jects were all healthy, and they were not ﬁrst-degree relatives of
each other, according to self-report. For the AMI groups, the DNA
samples were chosen after initial screening of samples, to exclude
individuals with large EUR admixture. This was performed using
AIMs and criteria (to remove outliers) as described elsewhere.13
Of AMI samples, !10% were excluded on this basis. MAM were
randomly chosen from a previous set of subjects,12 with the ex-
clusion of 2 individuals (of 94) with evidence of African contri-
bution 110%.
Statistical Methods
was determined using Genetix software, which applies theFST
Weir and Cockerham algorithm.22 Hardy-Weinberg equilibrium
was examined using an exact test implemented in the FINETTI
software, which can be accessed interactively (Institut fur Hu-
mangenetik). Population admixture proportionsweredetermined
using the Bayesian clustering algorithms developed by Pritchard
and implemented in the program STRUCTURE (v. 2.1).23,24 Indi-
vidual admixture proportions and the number of generations
since admixture were determined using STRUCTURE 2.1 and
ADMIXMAP.
For STRUCTURE, each analysis was performed without any
prior population assignment and was performed at least three
times, with similar results, with use of 15,000 replicates and 2,000
burn-in cycles under the admixture model. We used the “infer
a” option with a separate a estimated for each population (where
a is the Dirichlet parameter for degree of admixture). Runs were
performed under the option, where l parameterizes thelp 1
allele-frequency prior and is based on the Dirichlet distribution
of allele frequencies. The log likelihood of each analysis at varying
numbers of population groups (k) is also estimated in the STRUC-
TURE analysis and, as expected, favored two population groups
in the MAM. For analyses using different values of k ( , 3, 4,kp 2
5, or 6), at least 95% of the ancestry in the MAM population was
derived from two clusters that corresponded to the AMI and EUR
clusters. For ADMIXMAP analysis of the MAM genotypes, 23,000
iterations and 2,000 burn-in cycles were used under the random-
mating model. The runs were performed under prior allele-fre-
quency estimation with use of the results of the parental allele–
frequency determinations. The number of generations was al-
lowed to vary and thus was determined for each gamete by the
Markov chain–Monte Carlo (MCMC) algorithm.
Admixturemapping of simulated data sets was performedusing
ADMIXMAP.1 This program evaluates evidence of ancestry link-
age by application of a score test to either case-only or case-con-
trol analyses. For case-only analysis, the null hypothesis is that
the risk ratio between populations at each locus equals one. For
case-control analysis, the null hypothesis is that there is no effect
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on locus ancestry, compared with individual admixture. For both
analyses, the ancestral transitions are derived from application
of the MCMC algorithm.
The simulations were performed by modiﬁcation of a program
developed elsewhere.4 Most runs were performed using 2,000 it-
erations and 400 burn-in cycles. Similar results were obtained
using longer runs (23,000 iterations and 2,000 burn-in cycles),
and monitoring of ergodic averages showed the sampler had run
long enough for the posterior means to have been estimated ac-
curately. A normalized score of 4.0 was found to approximate a
conservative genomewide a level (∼0.01), on the basis of large
numbers of simulations run under different conditions (i.e., with
different ethnicity risk ratios [ERRs] and genomic intervals).
Genotyping and SNP Sets
Three different genotyping platforms and four different sets of
SNPs were used in this study: (1) Illumina array platform and
100K gene set (Illumina), (2) Illumina array platform and 317K
SNP set (HumanHap 300 BeadChip), (3) Perlegen Sciences pho-
tolithographic array and 20K SNPs selected for EUR/East Asian
allele-frequency differences, and (4) TaqMan assays and 40 SNP
AIMs. For the Illumina arrays, Perlegen Sciences arrays, and
TaqMan assays, the genotyping was performed and genotypes
assigned as described elsewhere.12,25–27 For the third set of SNPs,
the SNPs were chosen from the HapMap Project21 on the basis of
both EUR/East Asian values and genomic position. This strat-FST
egy was based on our previous studies showing enrichment for
AMI/EUR AIMs by use of this methodology.13
Genotypes from 60 unrelated subjects (parents) from CEU and
90 unrelated East Asian subjects (JPT and CHB HapMap data sets)
were available for ∼4 million SNPs in the combined phase 1 and
phase 2 HapMap results. Initial examination of these sets iden-
tiﬁed 1300,000 SNPs with an . High values favor se-F 1 0.25 FST ST
lection of markers that are closer to ﬁxation in one parental pop-
ulation. With use of the measurement, ∼30,000 SNPs wereFST
selected from this set of 300,000 SNPs by choosing a maximum
of 4 SNPs in 500-kb windows, with a minimum distance of 50
kb between SNPs. Additional SNPs were added in regions with
lower informativeness, SNPs were thinned in regions of high in-
formativeness, and SNPs that failed assay-design algorithms for
the Perlegen Sciences lithographic array platform were replaced
with other informative SNPs, to complete the set of 20,000 SNPs.
For all genotyping, SNPs were excluded if the results did not
meet either (1) 85% complete genotyping results in each popu-
lation group or (2) Hardy-Weinberg equilibrium criterion in any
of the parental populations ( ). These exclusion criteriaP ! .005
reduced the total number of SNPs by !2%.
Selection of EUR/AMI SNP AIMs for MAM Admixture
Mapping Panels
As described in the “Results” section, the SNP AIMs were chosen
on the basis of three criteria: (1) EUR/combined AMI valuesFST
10.35, (2) EUR/Pima and EUR/Mayan values both 10.3, andFST
(3) Pima/Mayan values !0.05. For one MAM admixture map-FST
ping panel, we optimized the choice of SNP AIMs from the 317K
Illumina array that were separated by a minimum of 50 kb. This
selection was performed by ﬁrst choosing the SNP with the
greatest value in each successive 100-kb bin and by then re-FST
moving the SNP AIM with the lower when two SNPs wereFST
present within a 50-kb interval. The same procedure was per-
formed with a combination of the three sets of SNP AIMs. These
SNP AIMs are provided in our Rich Text Format (RTF) ﬁles RTF1,
RTF2, RTF3, RTF4, and RTF5 (online only).
Genetic Map
For the present study, the analyses were performed using the
deCODE28 genetic maps. The position of each SNP was deter-
mined by interpolation with use of markers that were on the
genetic map and for which an unambiguous physical map po-
sition was available in National Center for Biotechnology Infor-
mation build 35. Any markers that were not in the same relative
order in both the genetic and physical maps were omitted as
anchors for the interpolation of the genetic positions of the SNPs.
SNP AIM Subsets
Smaller subsets of SNP AIMs examined in this study were derived
from the total SNP AIM set ( ) described above. A set ofnp 8,144
4,072 SNPs was chosen simply by selecting every other SNP AIM
in order of chromosomal position. A set of 5,287 SNPs enriched
for information content were obtained by (1) allowing a maxi-
mum of three SNPs in each 1-cM segment of the deCODE map
and (2) allowing only two SNPs in 1-cM segments of the deCODE
map if there were SNPs in both ﬂanking 1-cM segments, the sum
of the values was 11.0, and the segment was not within 10FST
cM of a chromosome end (RTF5 [online only]). In each case, our
method removed the SNP with the smallest value. Finally, aFST
set of 3,000 SNP AIMs was obtained by choosing the best SNP
AIM in each 1-cM bin.
The set of 39 SNP AIMs used for the comparisons of multiple
AMI groups by TaqMan assays included rs3768641, rs762656,
rs7504, rs1426654, rs262838, rs9847748, rs730570, rs4478653,
rs1880550, rs2380316, rs300152, rs6587216, rs7995033,
rs9295009, rs883399, rs2065160, rs2384319, rs1638567,
rs1266874, rs2165139, rs901304, rs17638989, rs814597,
rs6086473, rs1475930, rs1648180, rs293553, rs1951936,
rs2065982, rs1540979, rs734329, rs9937955, rs1931059,
rs6601288, rs953786, rs2439522, rs1417999, rs1572396, and
rs1418032.
Power Analysis
Power was assessed in MAM by simulations and ADMIXMAP an-
alyses, by use of marker-allele frequencies and map positions
(deCODE) for our current SNP sets. For each level of admixture
information, the disease allele was placed in the middle of one
of three different chromosomal regions that corresponded to the
level of admixture information being examined (for 80%, chro-
mosome 3 [138 cM], chromosome 5 [102 cM], and chromosome
14 [44 cM]; for 70%, chromosome 3 [80 cM], chromosome 4 [135
cM], and chromosome 13 [72 cM]; for 60%, chromosome 3 [152
cM], chromosome 6 [36 cM], and chromosome 14 [94 cM]). Sim-
ulations (1150 for each ERR) were performed using a 15-gen-
eration continuous-gene-ﬂow (CGF) model and 50:50 EUR:AMI
admixture.
Results
Screening of EUR/AMI SNP AIMs
To develop a genomewide panel of EUR/AMI SNP AIMs,
the genotypes of EUR subjects and Pima AMI subjects were
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Table 1. Summary of SNP-Screening Results for SNPs with EUR/Pima Values 10.3FST
EUR/Pima
FST
No. of SNPs with EUR/Mayan ValuesFST
.0–.1 .1–.2 .2–.3 .3–.4 .4–.5 .5–.6 .6–.7 .7–.8 .8–.9 .9–1.0
.3–.4 2,981 3,716 6,158 6,040 2,083 699 215 41 0 0
.4–.5 909 1,419 2,175 3,411 3,023 1,082 388 102 9 0
.5–.6 316 403 665 1,179 1,771 1,524 636 165 23 1
.6–.7 97 104 177 329 566 1,008 810 251 60 8
.7–.8 12 7 28 68 129 274 452 356 108 11
.8–.9 0 0 2 8 10 23 73 129 148 36
.9–1.0 0 0 0 0 0 0 0 2 7 25
NOTE.— values were calculated using the Weir and Cockerham method.22FST
Table 2. Comparison of Values forFST
EUR/AMI AIMs
Population
forFST
EUR Pima Mayan Nahua
Pima .645
Mayan .632 .015
Nahua .585 .027 .019
Quechuan .543 .039 .028 .027
NOTE.—Results are mean values for 39 SNPFST
AIMs (see the “Methods” section) meeting ini-
tial criteria of EUR/Pima , EUR/MayanF 1 0.3ST
, and Pima/Mayan . The as-F 1 0.25 F ! 0.05ST ST
says were performed using a minimum of 48
EUR, Pima, and Quechuan subjects and a mini-
mum of 24 Nahua subjects.
initially examined for three sets of SNPs: (1) gene-rich
100K Illumina array, (2) 317K Illumina array, and (3) a set
of 20,000 SNPs enriched for large allele-frequency dif-
ferences between EUR and East Asian populations. Ge-
notypes were ascertained or available for the following
subject sets: set 1, 192 EUR and 24 Pima; set 2, 222 EUR
and 23 Pima; and set 3, 74 EUR and 72 Pima. A total of
1400,000 unique SNPs that were not excluded by our qual-
ity assessment were analyzed for allele-frequency differ-
ences. For the combined sets, analysis of the EUR/Pima
allele frequencies showed a total of 46,450 SNPs with
and 11,999 SNPs with .F 1 0.30 F 1 0.5ST ST
To validate the identiﬁcation of SNPs informative for
EUR versus AMI ancestry, we performed a second screen,
using DNAs from subjects of Mayan AMI ancestry (set 1,
16 subjects; set 2, 24 subjects; set 3, 29 subjects). Mayan
subjects were chosen for this conﬁrmation since they are
part of another AMI group, distinct from Pima AMI, who
are members of the larger Ito-Aztecan AMI grouping and
whose ancestors are thought to have provided a large con-
tribution to admixed populations in southernMexico. The
majority of SNPs with large EUR/Pima differences (F 1ST
) also had large EUR/Mayan allele-frequency differences0.3
(table 1). Interestingly, there were a substantial number
of SNPs that showed large differences between the Mayan
and Pima AMIs. For example, of the SNPs with EUR/Pima
, 3.5% (425 of 12,001) showed a EUR/MayanF 1 0.5ST
, and 7.8% (939 of 12,001) showed a EUR/MayanF ! 0.1ST
. This was not due simply to relatively small num-F ! 0.2ST
bers of AMI subjects, because, when two different inde-
pendent sets of 24 Pima AMI were genotyped with the
same SNPs, very few SNPs showed this phenomenon. Of
2,334 SNPs with EUR/Pima in the ﬁrst set of 24F 1 0.5ST
Pima individuals, only 2 (0.1%) showed a EUR/Pima F !ST
and only 6 (0.3%) showed a EUR/Pima in a0.1 F ! 0.2ST
second independent set of 24 Pima AMI. In addition, there
was a substantially lower frequency of SNPs with disparate
results in the two AMI groups in the SNPs selected for
EUR/East Asian differences. For the latter group, 0.6% of
SNPs with EUR/Pima values 10.5 showed EUR/MayanFST
.F ! 0.01ST
We next examined whether either Pima or Mayan in-
dividuals alone could adequately represent the AMI con-
tribution to MAM. Using 24 MAM typed in the 317K Il-
lumina array, we compared results, using sets of 1100 un-
linked AIMs with the following different characteristics:
(1) EUR/Pima and EUR/Mayan , (2) EUR/PimaF 1 0.35ST
and EUR/Mayan , and (3) EUR/MayanF 1 0.35 F ! 0.15ST ST
and EUR/Pima . When STRUCTUREF 1 0.35 F ! 0.15ST ST
was used, the three sets of AIMs showed different results.
When SNPs without differences between the two AMI
groups were used, the EUR:AMI admixture ratiowas 0.531:
0.469, whereas a smaller AMI contribution was estimated
using the sets showing inter-AMI differences: EUR:AMIp
:0.293 for group 2, and EUR: :0.352 for0.703 AMIp 0.648
group 3. From these studies, we hypothesize that SNP AIMs
showing differences between these two AMI groups are
likely to underestimate the AMI ancestry within the ad-
mixed MAM population. On the basis of these studies, we
limited our further analyses to those AIMs with combined
EUR/AMI , EUR/Pima , EUR/MayanF 1 0.35 F 1 0.3 F 1ST ST ST
, and relatively small allele-frequency differences be-0.3
tween Pima andMayan AMI ( ), because inclusionF ! 0.05ST
of SNPs with large inter-AMI differences may lead to mis-
leading ancestry information for some chromosomal seg-
ments in admixture mapping studies. A summary of the
results for each of the individual SNPs (25,596 SNP AIMs)
meeting these criteria is provided in RTF1 (online only).
Additional studies were performed to ascertain whether
most SNPs selected using both Pima and Mayan screens
would be useful in many EUR/AMI admixed populations.
A subset of 39 AIMs with these characteristics were ex-
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Table 3. Estimation of the Number of
Generations since Admixture for MAM
Chromosome
Mean No. ( SD)
of Generations SNPs Used
STRUCTURE ADMIXMAP No.
Size
(cM)
1 13.21.1 12.35.3 530 274
2 17.21.4 16.87.3 597 263
3 14.61.2 15.26.0 487 221
4 15.91.6 14.36.5 401 205
5 16.81.7 12.85.1 417 206
6 18.81.8 17.69.1 436 189
7 13.91.4 14.77.5 345 188
8 18.31.8 18.79.6 370 167
9 13.51.4 14.57.5 290 160
10 18.01.9 16.17.2 337 180
11 24.02.5 25.211.7 325 153
12 13.81.4 11.76.1 310 172
13 14.31.8 11.54.3 244 129
14 13.01.7 8.43.9 238 125
15 16.02.1 14.07.4 226 134
16 11.71.5 9.85.3 193 136
17 18.93.5 9.54.0 170 136
18 16.02.6 11.26.0 189 122
19 9.81.8 5.42.9 136 110
20 12.11.8 8.13.9 168 112
21 16.43.2 11.56.3 97 77
22 19.12.9 13.05.6 106 71
NOTE.—Estimations were performed using the 6,897 Il-
lumina 317K SNP AIMs (see RTF3 [online only]) for 24
MAM subjects.
amined by genotyping an additional set of EUR, another
Ito-Aztecan AMI group (Nahua), and a third disparate AMI
group (Quechuan) from South America (Peru). ThoseAIMs
with EUR/AMI 10.35 and Pima/Mayan showedF F ! 0.05ST ST
large EUR/Nahua, large EUR/Quechuan, and small intra-
AMI values (table 2). For each SNP, the individual intra-FST
AMI value was !10% of the EUR/AMI , which sug-F FST ST
gests that our screen with two disparate AMI groups is an
effective strategy for ascertaining SNPs that may be useful
for many AMI admixed populations.
Estimation of Admixture Characteristics of MAM
The number of generations since admixture is a parameter
necessary for power simulations in admixture mapping.
We used a set of 24 MAM subjects genotyped using the
317K Illumina panel to provide an estimate of the number
of generations since admixture. For these estimates, only
the AIMs with EUR/AMI and Pima/MayanF 1 0.30 F !ST ST
were used (RTF2 [online only]). In addition, we se-0.05
lected each SNP AIM to have a minimum 50-kb inter-
marker distance, to minimize the effects of LD in parental
populations that may affect the probability of ancestry
assignment (RTF3 [online only]). Although this set of AIMs
does not provide the level of genomewide coverage of the
entire AIMs set (including two additional SNP screens),
the density of markers was sufﬁcient to enable extraction
of the majority of ancestry information (presented below).
Analyses with use of both STRUCTURE and ADMIXMAP
were performed for each chromosome (table 3). The av-
erage number of generations varied for each chromosome,
probably because of the small sample size, since the ad-
mixture mapping information was similar for each chro-
mosome. The STRUCTURE and ADMIXMAP algorithms
showed a mean (SD) of and gen-15.7 3.15 13.3 4.1
erations, respectively. The number of generations for each
chromosome estimated using these two algorithms were
highly correlated ( ; , by paired t test).2r p 0.60 Pp .0004
The difference between the STRUCTURE and ADMIXMAP
estimations is probably due to the difference between
these algorithms; STRUCTURE estimates the admixture
generation for each individual, whereas ADMIXMAP es-
timates the number of generations for each gamete sep-
arately. On the basis of these results, we chose 15 gener-
ations as a reasonable estimation of the number of gen-
erations since admixture. If this is an overestimate, then
the admixture mapping coverage would be greater; con-
versely, if this is an underestimate, then the coveragewould
be lower than that shown in our simulation studies.
Assessment of Genomewide Information Content
of EUR/AMI AIMs
The ability of the EUR/AMI AIMs to extract admixture
mapping information was assessed using ADMIXMAP.1 AD-
MIXMAP determines the ability to assign ancestry along
the chromosome in the admixed population with use of
the ratio of the observed information about the ancestry
risk ratio compared with the complete information that
would be extracted if locus ancestry and parental-admix-
ture proportions were observed directly. The extracted in-
formation in the admixed population is determined on
the basis of the ancestry information content of themark-
ers, the genetic map, and the empiric assessment of the
admixture model (number of generations since admixture
for each gamete). For estimation of the admixture map-
ping information, we used the mean extracted informa-
tion between adjacent SNPs as the information content
of each interval. The analyses are based on simulating the
MAM subjects with use of 15 generations and a contin-
uous-gene-ﬂow model (see the “Methods” section). This
estimated admixture mapping information was calculated
for the entire set of 8,144 SNP AIMs (RTF4 [online only])
that met our criteria (EUR/AMI and Pima/MayanF 1 0.30ST
) and for smaller subsets of AIMs, including thoseF ! 0.05ST
with only the 317K Illumina array SNPs (ﬁg. 1 and table
4). The complete panel of 8,144 SNP AIMs extract 150%
of the admixture information for 199% of the genome
and 160% of the admixture information for 185% of the
genome. With use of 5,287 SNPs selected for informa-
tiveness (RTF5 [online only]), the coverage was only mar-
ginally decreased for these levels of extracted admixture
information. A set of 6,897 SNP AIMs derived exclusively
from the 317K Illumina SNPs also provided good levels
of admixture mapping information but was marginally
worse than the selected 5,287 SNP AIMs set (table 4).
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Table 4. Genomewide Admixture Mapping Information for
SNP AIM Panels
Admixture
Mapping
Information
(%)
Genomic Coverage by SNP AIM Panel
(%)
Complete Half
Selected
5K
Selected
3K
317K
Illumina
80 19 3 6 0 12
70 58 18 44 10 45
60 88 53 84 57 79
50 99 84 99 93 96
NOTE.—Results are based on simulations with use of the actual EUR
and AMI allele frequencies and deCODE genetics map positions. The
simulations were performed using EUR:AMI 50:50 admixture proportions,
15 generations, and a CGF model. The Complete SNP AIM panel contains
the largest set of AIMs (8,144 SNPs) with minimum intermarker distance
of 50 kb that meet our AIMs criteria (see the “Screening of EUR/AMI
SNP AIMs” section and RTF4 [online only]). The Half set contains every
other marker from the complete SNP AIM panel. The Selected 5K panel
contains 5,287 SNPs that were selected as described in the “Methods”
section, to optimize mapping information in a reduced SNP AIMs panel.
Similarly, the Selected 3K panel was also chosen to optimize admixture
mapping information in a smaller set of SNP AIMs. The 317K Illumina
panel contains the largest set (6,897 SNPs) derived exclusively from the
Illumina array with a minimum intermarker distance of 50 kb.
Figure 1. Admixture mapping distribution for each chromosome. The admixture mapping information (ordinate) is shown for each
position on the deCODE sex-average map. The information was determined using the ADMIXMAP analysis of genotyping results with
use of 8,144 SNP AIMs.
Smaller sets of SNP AIMs, with choice of either every other
SNP from the total set or of the best SNP AIM in 1-cM
bins (selected 3K set), showed larger decreases in admix-
ture mapping information.
Analysis of Power with Use of Simulated Data Sets
To examine the relative efﬁcacy of admixture mapping
with use of different densities of AIMs, we examined sim-
ulationmodels using different ERRs, where ERR is the ratio
of the risk attributed to one parental population compared
with the other parental population in the admixed pop-
ulation.4 For each ERR, the power was examined for dif-
ferent regions corresponding to the level of extracted ad-
mixture mapping information (see the “Methods” sec-
tion). For each model, both case-only and case-control
analyses were performed using the same case sample size
(ﬁg. 2). The power for the case-control analyses was mod-
estly less than that for the case-only analyses. This result
contrasts with previous results of similar admixture map-
ping–power analyses in AFA, where the power is substan-
tially higher in case-only compared with case-control
analyses. Also, in contrast to AFA admixture mapping,19
good power is still observed with 0.6 admixture mapping
information at an . These results, together withERRp 1.5
our analysis of admixture mapping information, suggest
that the current SNP AIMs provide good power for admix-
ture mapping.
We also assessed the CIs that can be achieved with ad-
mixture mapping in MAM. The CI to which a suscepti-
bility locus could be assigned was examined using a 2-
SCORE fall-off in probability in the ADMIXMAP analysis.
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Figure 2. Power for admixture mapping as a function of admix-
ture mapping information. The power was determined from sim-
ulations with 800 cases and 800 controls and SNP sets with ad-
mixture information corresponding to the legend for the SNP set
used (see the “Methods” section). The power curves were deter-
mined using the ADMIXMAP program and deCODE genetics map for
either case only (CO) or case control (CC). The appropriate a level
for these analyses was a normalized score of 4.0, based on ex-
tensive simulations. The result for each measurement point is
based on a minimum of 50 separate simulations for each of three
different genomic positions and analyses. The simulations were
performed with the assumption of 15 generations, a continuous-
gene-ﬂow model, and 50:50 EUR:AMI admixture. The power sim-
ulations were performed under an additive model. Previous studies
have shown similar power for additive, multiplicative, and even
recessive models when the theoretic limits (ancestry for each seg-
ment known) are examined.29
Table 5. Evaluation of CIs for
Admixture Mapping with SNP AIMs
ERR, Population,
and Analysis
CI by Information Level
(cM)
80% 60%
1.75:
MAM:
Case-control 2.8.9 3.81.8
Case only 2.4.7 2.81.7
AFA:
Case-control 17.37.7 24.89.2
Case only 15.14.6 23.56.9
1.5:
MAM:
Case-control 5.11.5 7.02.8
Case only 4.81.6 6.03.3
AFA:
Case-control 18.87.3 22.94.6
Case only 19.37.1 28.410.3
NOTE.—The CIs were determined by the length
in cM (1 SD) for a 2-SCORE drop off in ADMIXMAP
signiﬁcance from the peak SCORE. For both MAM
and AFA, the analyses were based on three dif-
ferent genomic intervals for each level of admix-
ture mapping information (80% or 60%) and in-
cluded 1100 simulations. The MAM analyses were
performed using the complete AIM SNP set in the
current study (8,144 SNPs), and the AFA analyses
were performed using the complete AFA SNP AIM
set (4,222 SNPs), as described elsewhere.19
This was examined as a function of both ERR and admix-
ture mapping information (table 5). The results show that
the critical regions in MAM are substantially smaller than
those observed using data from similar analyses of AFA
subjects under admixture mapping parameters appropri-
ate for this admixed population.19 This is true, even when
the greater admixture mapping information that can be
extracted in AFA is considered—for example, by compari-
son of 0.6 admixture mapping information in MAM
( cM for , case only) and 0.8 ad-CIp 6.0 3.3 ERRp 1.75
mixture mapping information extraction in AFA (CIp
for , case only).15.1 4.6 ERRp 1.75
Discussion
The current study provides a set of 8,144 SNP AIMs that
are useful for admixture mapping in EUR/AMI admixed
populations. Our studies suggest that these genomewide
SNP AIMs can differentiate EUR and AMI ancestry inmany
admixed population with predominant contributions from
these two parental groups. The SNPs were selected on the
basis of a standard measurement of interpopulation dif-
ference ( ) through use of SNPs with only small intra-FST
population differences. For AMI, as presented in our “Re-
sults” section, only SNPs with between MayanF ! 0.05ST
and Pima AMIwere used. For EUR, the differences between
different EUR populations are very small (mean intrapop-
ulation values !0.01 and 199% of SNPs with valuesF FST ST
!0.05), even when disparate EUR groups—for example,
Italian versus Swedish—are examined30 (M.F.S., unpub-
lished data). Further studies will be necessary to conﬁrm
that these SNPs adequately inform all AMI admixture in
MAM and to extend the application of these SNP AIMs to
other AMI admixed populations, such as South American
populations. Although our preliminary studies of another
disparate AMI group (Quechuan from Peru) suggest that
many of these AIMs will be applicable to such investiga-
tions, it should be emphasized that large differences in
allele frequencies observed in several AMI populations16,
17 will require empirical testing of these AIMs in multiple
AMI groups to determinemore general applicability of this
AIM set.
Recently, a study suggested that it may be preferable to
perform admixture mapping using SNP panels for whole-
genome association.31 This strategy has the beneﬁt of pro-
viding additional information for linkage disequilibrium
to disease traits that is not dependent on continental an-
cestry linkage. Although this may be a practical approach,
depending on the cost of whole-genome panels (e.g., 317K
or 500K SNP arrays) comparedwith that of selective panels
of 5,000–10,000 SNPs, our results introduce a major ca-
veat—that is, that special considerations are necessary to
adjust for potential variation in parental-population allele
frequencies in the AMI population. Thus, we suggest that
such a strategy requires genotyping at least two disparate
AMI groups and the use of only SNP AIMs that meet cri-
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Figure 3. Clustering of SNPs showing large between Pima and Mayan AMIs on chromosome 6. The ordinate shows the number ofFST
markers with Pima/EUR in each 2 cM (above abscissa) and the frequency of all SNPs (below abscissa). The abscissa shows theF 1 0.35ST
chromosome position in cM. The results are from analysis of genotypes with use of the 317K Illumina array. The same peak is also
observed in the 100K gene-enriched array after removal of all SNPs overlapping with the 317K Illumina array. The peak could not be
explained by the density of SNPs on the genetic map, which averaged 122 SNPs/cM on chromosome 6 and was 196 SNPs/cM in the
HLA region.
teria similar to those used here—that is, EUR/AMI F 1ST
and inter-AMI . SNPs with lower ratios of0.30 F ! 0.05ST
intercontinental information compared with intra-AMI
differences may inhibit accurate ancestral deﬁnition of
chromosomal segments. For the Illumina 317K set, the
current study provides such a list of SNPs that can be used
for admixture mapping (RTF2 and RTF3 [online only]).
However, the admixture mapping coverage is less than
that obtained using the panel of SNP AIMs derived from
multiple sources (table 4).
In screening for EUR/AMI AIMs, we observed a higher
percentage of SNPs with large allele-frequency differences,
using the 100K gene-rich panel (2.78%with ), com-F 1 0.5ST
pared with the percentage when we used the Illumina
317K panel (2.34% ) ( ). In addition, whenF 1 0.5 P ! .001ST
we examined the 317K SNP results, the EUR/AMI valuesFST
observed for SNPs within genes ( ) were signif-F p 0.116ST
icantly greater than those for SNPs within noncoding
regions ( ) ( , by t test). This re-141F p 0.101 Pp 2.8# 10ST
sult, similar to those of other studies, suggests that positive
selection may be an important feature in shaping the ge-
nomes of different continental populations.27,32–34 Further
analysis did not show a difference between synonymous
and nonsynonymous base-pair differences within genes
(3.7% for both groups). However, this lack of dif-F 1 0.5ST
ferencemay reﬂect the relatively large regions that are part
of selective sweeps. These data are generally consistent
with previous studies that also did not show large dif-
ferences between synonymous and nonsynonymous base
changes, in contrast to genic versus nongenic SNPs.27
It is noteworthy that the proportion of SNPs with large
frequency differences between Pima and Mayan AMIs are
also greater in the 100K gene array than in the 317K SNP
array. For SNPs with EUR/Pima , we observed aF 1 0.3ST
larger frequency of Pima/Mayan in the 100K (2.6%)F 1 0.3ST
than in the 317K array (2.1%). Finally, we also observed
a clustering of many of the SNPs with large frequency
differences between Mayan and Pima AMIs. Notably, when
2-cM intervals were examined, the greatest number of
SNPs with large Mayan/Pima differences was observed on
chromosome 6, within the human leukocyte antigen (HLA)
region (ﬁg. 3). Whereas some of the clustering of these
SNPs is due to the uneven frequency distribution of SNPs
along the chromosome, the frequency of SNPs with high
Pima/Mayan (97 of 1,547 within the HLA region) com-FST
pared with the frequency of SNPs in the rest of chromo-
some 6 (42 of 19,171) was markedly different ( ,P ! .0001
by two-tailed x2 test). These preliminary observations sug-
gest the potential value of further studies that address the
possibility that positive selection is important in shaping
differences between subcontinental populations and the
possibility that such studies may suggest variations of bi-
ologic importance, as has been previously advanced for
continental populations.21,34
The current study enables admixture mapping studies
to be extended to MAM. This is likely to be particularly
important in studies of diseases, such as type 2 diabetes
and rheumatoid arthritis, that have a higher prevalence
in AMI than in EUR populations.9,10,35–37 This marker set
will be used for mapping by admixture linkage disequi-
librium (MALD) in the MAM MALD sample of the Family
Investigation of Nephropathy and Diabetes, as described
elsewhere.8 Admixed populations and admixturemapping
can be particularly useful in studying complex diseases,
since there is the potential to map and identify genes that
are not sufﬁciently polymorphic in either parental popu-
lation. In addition, admixture mapping is less sensitive
to independent mutations of the same susceptibility gene
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than are association methods, since identiﬁcation of chro-
mosomal regions depends on ancestry association and
is not deterred by multiple haplotypes in the parental
population.
It is worth noting that, in comparison with AFA, the
admixture ratios in MAM both in the United States and
Mexico are much closer to an equal contribution of the
two parental populations12,13,38 and that the number of
generations since admixture is substantially greater. This
larger number of average generations since admixture leads
to a requirement for a much larger set of AIMs for ex-
tracting admixturemapping information.Our simulations
suggest that over double the number of AIMs are necessary
to extract comparable levels of information, compared
with our similar studies in AFA.19 However, for power, the
near-equal admixture of parental populations compen-
sates for the lower information content of AIMs, consis-
tent with previous simulation studies.2,29 Thus, the current
study suggests that admixture mapping in MAM is po-
tentially more powerful than in AFA. Similarly, although
the current AIMs panel provides good admixturemapping
information when the parental admixture proportions de-
viates from 50:50 (e.g., for the 70:30 EUR:AMI simulation,
the AIMs panel shows 0.75 genomewide coverage com-
pared with 0.88 for the 50:50 admixture proportionwhen
60% admixture mapping information is considered), the
admixture mapping power will decrease in populations
when there is a much larger contribution from only one
parental population. This effect on power is greatest when
the ERR is modest, the admixture ratios are more extreme,
and the susceptibility gene derives from the parental pop-
ulation with the larger contribution.2,29 In addition, it
is notable that the increased number of generations de-
creases the length of the chromosomal region in which
susceptibility genes of comparable ERRs can be located
(table 5). Additional studies will be necessary to explore
the power and ability of these methods to be applied
to admixture populations with large contributions from
three continental populations, such as for the Puerto Ri-
can population.12 In summary, the current study should
provide an initial set of AIMs for extending admixture
mapping studies to large populations with EUR and AMI
admixture.
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